Get the latest BPUR - Biopure Corporation Class A stock market performance data and financial news.
Get the latest BPUR - Biopure Corporation Class A together with stock market performance data and financial news.
Get the latest BPUR - Biopure Corporation Class A stock market performance data and financial news.
Read Jim Cramer's take on Biopure Corporation Class A (BPUR) and get his latest thoughts on the company?s performance and outlook
... Totally Biopure. 9/17/03 03:45 PM ET. More bluster and blather (and nothing new)
from Biopure (BPUR-Nasdaq) management today at the ThinkEquity conference. ...
http://www.thestreet.com/p/dps/cc/20030917/columnistconversation7.html
... By the way, my goal this morning was to attend the Biopure (BPUR:Nasdaq) breakout
session. I guess I'll have to get my information some other way. No worries. ...
Stock portfolio management made easy with updated quotes, investing tools and financial advice. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
Genta plunges as regulators say its cancer treatment is not approvable.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10328200/1/fridays-health-winners-losers.html
Flotek sinks.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10387877/1/thursdays-small-cap-winners-losers.html
The Food and Drug Administration refused to approve the human blood substitute, Polyheme, for use in trauma patients suffering from severe blood loss.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10494881/1/northfield-blood-substitute-rejected-by-fda.html
Connect with TheStreet